Combination antifungal therapy for cryptococcal meningitis

New England Journal of Medicine

Volumn 368, Issue 14, 2013, Pages 1291-1302

  Day, Jeremy N ^a,c   Chau, Tran T H ^a,b   Wolbers, Marcel ^a,c   Mai, Pham P ^b   Dung, Nguyen T ^b   Mai, Nguyen H ^a,b   Phu, Nguyen H ^a,b   Nghia, Ho D ^a,b   Phong, Nguyen D ^b   Thai, Cao Q ^a   Thai, Le H ^a   Chuong, Ly V ^b   Sinh, Dinh X ^b   Duong, Van A ^a   Hoang, Thu N ^a   Diep, Pham T ^a   Campbell, James I ^c   Sieu, Tran P M ^b   Baker, Stephen G ^a,c   Chau, Nguyen V V ^b   Hien, Tran T ^a,c   Lalloo, David G ^d   Farrar, Jeremy J ^a,c   more..

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; FLUCONAZOLE; FLUCYTOSINE;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ANEMIA; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG ERUPTION; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEMATEMESIS; HUMAN; HYPERCREATINEMIA; HYPERKALEMIA; HYPERTRANSAMINASEMIA; HYPOKALEMIA; HYPONATREMIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NAUSEA AND VOMITING; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RIGOR; SEIZURE; SEPSIS; SURVIVAL RATE; THROMBOCYTOPENIA; THROMBOPHLEBITIS; TREATMENT DURATION; TREATMENT OUTCOME; URINE RETENTION;

EID: 84875765407     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1110404     Document Type: Article

References (25)

1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009;23:525-30.
2. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010;50:291-322.
3. van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997;337:15-21. (Pubitemid 27290842)
4. Sloan D, Dlamini S, Paul N, Dedicoat M. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings. Cochrane Database Syst Rev 2008;4:CD005647.
5. Brouwer AE, Rajanuwong A, Chierakul W, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet 2004;363:1764-7. (Pubitemid 38698379)
6. Bicanic T, Wood R, Meintjes G, et al. High-dose amphotericin with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis 2008;47:123-30. (Pubitemid 351920599)
7. Longley N, Muzoora C, Taseera K, et al. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda. Clin Infect Dis 2008;47:1556-61.
8. Pappas PG, Chetchotisakd P, Larsen RA, et al. A phase II randomized trial of amphotericin alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis 2009;48:1775-83.
9. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351:1741-51.
10. Page RDM, Holmes EC. Molecular evolution: a phylogenetic approach. London: Blackwell Science, 1998.
11. Proschan MA, Waclawiw MA. Practical guidelines for multiplicity adjustment in clinical trials. Control Clin Trials 2000;21:527-39. (Pubitemid 32056216)
12. Schulz KF, Grimes DA. Multiplicity in randomised trials I: endpoints and treatments. Lancet 2005;365:1591-5. (Pubitemid 40615409)
13. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2010 (http://www.R-project.org).
14. Van Buuren S, Groothuis-Oudshoorn K. MICE: Multivariate Imputation by Chained Equations in R. J Stat Softw 2011 (http://www.jstatsoft.org/v45/i03/ paper).
15. Bretz F, Hothorn T, Westfall P. Multiple comparisons using R. Boca Raton, FL: CRC Press, 2010.
16. Bicanic T, Muzoora C, Brouwer AE, et al. Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis 2009;49:702-9.
17. Rozenbaum R, Gonçalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994;18:369-80. (Pubitemid 24086307)
18. Chuck SL, Sande MA. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989;321:794-9. (Pubitemid 19237427)
19. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-9.
20. Pitisuttithum P, Tansuphasawadikul S, Simpson AJ, Howe PA, White NJ. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B. J Infect 2001;43:226-33. (Pubitemid 34100463)
21. Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000;30:47-54. (Pubitemid 30067061)
22. Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O. Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS Med 2007;4(2):e21.
23. Loyse A, Wilson D, Meintjes G, et al. Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis. Clin Infect Dis 2012;54:121-8.
24. Saag MS, Cloud GA, Graybill JR, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999;28:291-6.
25. Dromer F, Bernede-Bauduin C, Guillemot D, Lortholary O. Major role for amphotericin B-flucytosine combination in severe cryptococcosis. PLoS One 2008;3(8):e2870.